Publications by authors named "David Totschnig"

Claim this Profile
M
Meropenem plasma concentrations in critically ill patients treated with the novel multi organ replacement therapy ADVOS.
David Totschnig, Theresa Mader, Thomas Stimpfl, Klaus Breinbauer, Cristina Groza

Infection· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients.
Moritz Platzer, David Totschnig, Mario Karolyi, Tamara Clodi-Seitz, Christoph Wenisch

Wien Klin Wochenschr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2.
Cristina Groza, David Totschnig, Christoph Wenisch, Johanna Atamaniuk, Alexander Zoufaly

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19.
Victoria Kauer, David Totschnig, Ferdinand Waldenberger, Max Augustin, Mario Karolyi

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19.
Hannes Vietzen, Philippe L Furlano, Marianna Traugott, David Totschnig, Wolfgang Hoepler

J Med Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysis.
Mario Karolyi, Lukas Kaltenegger, Erich Pawelka, Avelino Kuran, Moritz Platzer, David Totschnig

Wien Klin Wochenschr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center Experience.
David Totschnig, Max Augustin, Iulia Niculescu, Hermann Laferl, Sonja Jansen-Skoupy

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab.
David Totschnig, Daniel Doberer, Renate Haberl, Christoph Wenisch, Arschang Valipour

IDCases· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whipple's disease diagnosed in a patient with suspected sarcoidosis.
David Totschnig, Tamara Seitz, Alexander Zoufaly, Sabine Hagenauer-Drektraan, Christoph Wenisch

Int J Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis